In mouse models of melanoma, NK or CD8+ T cell depletion caused significant reduction in the survival of melanoma when treated with anti-PD-1 + anti-CTLA-4, supporting the hypothesis that NK and CD8+ T cells cooperate with each other to eradicate the tumor in response to these therapies [222]. Here, PDCD1 is linked to melanoma.